Mirvaso
- Product NDC
- 0299-5980
- 11-digit product format
- 002995980
- Labeler code
- 0299
- Product ID
- 0299-5980_253bf4a2-3c4d-f4af-e063-6394a90a0b0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brimonidine tartrate
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Galderma Laboratories, L.P.
- Application
- NDA204708
- Marketing category
- NDA
- Marketing start
- 2013-08-23
- Substance
- BRIMONIDINE TARTRATE
- Active strength
- 5 mg/g
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mirvaso
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BRIMONIDINE TARTRATE | 5 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4S9CL2DY2H |
| Rxcui | 1437707, 1437709 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BRIMONIDINE TARTRATE | ACTIVE INGREDIENT | 4S9CL2DY2H | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| BRIMONIDINE | ACTIVE MOIETY | E6GNX3HHTE | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| Carbomer Homopolymer Type B (allyl Pentaerythritol Crosslinked) | INACTIVE INGREDIENT | HHT01ZNK31 | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0299-5980 | MIRVASO (BRIMONIDINE TARTRATE) GEL [GALDERMA LABORATORIES, L.P.] | 11 | Current NDC, Legacy NDC, 7 package rows | 20241027_f6a4353f-ae69-4214-901f-e5d42a6fbde7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0299-5980-00 | 00299598000 | 1 TUBE in 1 BLISTER PACK (0299-5980-00) / 2 g in 1 TUBE | 1 tube | 2013-08-23 | 0000-00-00 | Yes | No | Current |
| 0299-5980-02 | 00299598002 | 2 g in 1 TUBE (0299-5980-02) | 2 g | 2013-08-23 | 0000-00-00 | Yes | No | Current |
| 0299-5980-30 | 00299598030 | 30 g in 1 TUBE (0299-5980-30) | 30 g | 2013-08-23 | 0000-00-00 | No | No | Current |
| 0299-5980-35 | 00299598035 | 1 BOTTLE, PUMP in 1 CARTON (0299-5980-35) / 30 g in 1 BOTTLE, PUMP | | 2013-08-23 | 0000-00-00 | No | No | Current |
| 0299-5980-45 | 00299598045 | 45 g in 1 TUBE (0299-5980-45) | 45 g | 2013-08-23 | 0000-00-00 | No | No | Current |